Evidence of long-lasting anti-CD19 activity of engrafted CD19chimeric antigen receptor–modified T cells in a phase I studytargeting pediatrics with acute lymphoblastic leukemia

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalHematological Oncology
Publication statusPublished - 2019

Cite this